Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages

Biochemical and Biophysical Research Communications

Volumn 245, Issue 3, 1998, Pages 698-704

  Kirikae, Teruo ^a   Ojima, Iwao ^b   Ma, Zhuping ^b   Kirikae, Fumiko ^a   Hirai, Yoshikazu ^a   Nakano, Masayasu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PACLITAXEL; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG POTENCY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALIA; MURINAE;

EID: 0032576991     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.8409     Document Type: Article

References (39)

1. Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T. J. Am. Chem. Sci. 93:1971;2325-2327.
2. Nogales E., Wolf S. G., Khan I. A., Ludueña R. F., Downing K. H. Nature (London). 375:1995;424-427.
3. Schiff P. B., B. H. S. Proc. Natl. Acad. Sci. USA. 77:1980;1561-1565.
4. Ding A. H., Porteu F., Sanchez E., Nathan C. F. Science. 248:1990;370-372.
5. Rietschel E. T., Kirikae T., Schade F. U., Mamat U., Schmidt G., Loppnow H., Ulmer A. J., Zahringer U., Seydel U., di Padova F., Schreier M., Brade H. FASEB J. 8:1994;217-225.
6. Morrison D. C., Ryan J. L. Annu. Rev. Med. 38:1987;417-432.
7. Nakano M., Shinomiya H. Bacterial Endotoxic Lipopolysaccharides, Volume I, Molecular Biochemistry and Cellular Biology. 1992;CRC Press, Boca Raton.
8. Sultzer B. M. Nature. 219:1968;1253-1254.
9. Manthey C. L., Qureshi N., Stutz P. L., Vogel S. N. J. Exp. Med. 178:1993;695-702.
10. Kirikae F., Kirikae T., Qureshi N., Takayama K., Morrison D. C., Nakano M. Infect. Immun. 63:1995;486-497.
11. Bogdan C., Ding A. J. Leukocyte Biol. 52:1992;119-121.
12. Kirikae T., Ojima I., Kirikae F., Ma Z., Kuduk S. D., Slater J. C., Takeuchi C. S., Bounaud P.-Y., Nakano M. Biochem. Biophys. Res. Commun. 227:1996;227-235.
13. Obayashi T., Tamura H., Tanaka S., Ohki M., Takahashi S., Arai M., Masuda M., Kawai T. Clin. Chim. Acta. 149:1985;55-65.
14. Ojima I., Zucco M., Duclos O., Kuduk S. D., Sun C. M., Park Y. H. Bioorg. Med. Chem. Lett. 3:1993;2479-2482.
15. Ojima I., Duclos O., Zucco M., Bissery M.-C., Combeau C., Riou J. F., Lavelle F. J. Med. Chem. 37:1994;2602-2608.
16. Ojima I., Park Y. H., Sun C.-M., Fenoglio I., Appendino G., Pera P., Bernacki R. J. J. Med. Chem. 37:1994;1408-1410.
17. Ojima I., Duclos O., Kuduk S., Sun C.-M., Slater J. C., Lavelle F., Veith J. M., Bernacki R. J. Bioorg. Med. Chem. Lett. 4:1994;2631-2634.
18. Ojima I., Park Y. H., Fenoglio I., Duclos O., Sun C.-M., Kuduk S. D., Zucco M., Appendino G., Pera P., Veith J. M., Bernacki R. J., Bissery M.-C., Combeau C., Vrignaud P., Riou J. F., Lavelle F. George G. I., Chen T. T., Ojima I., Vyas D. M. Taxane Anticancer Agents: Basic Science and Current Status. 1995;262-275 Am. Chem. Soc. Washington.
19. Ojima I., Duclos O., Dormán G., Simonot B., Prestwich G. D., Rao S., Lerro K. A., Horwitz S. B. J. Med. Chem. 38:1995;3891-3894.
20. Ojima I., Slater J. C., Michaud E., Kuduk S. D., Bounaud P.-Y., Vrignaud P., Bissery M.-C., Veith J., Pera P., Bernacki R. J. J. Med. Chem. 39:1996;3889-3896.
21. Ojima I., Kuduk S. D., Slater J. C., Gimi R. H., Sun C.-M. Tetrahedron. 52:1996;209-224.
22. Ojima I., Slater J. C., Kuduk S. D., Takeuchi C. S., Gimi R. H., Sun C. M., Park Y. H., Pera P., Veith J. M., Bernacki R. J. J. Med. Chem. 40:1997;267-278.
23. Ojima I. Acc. Chem. Res. 28:1995;383-389.
24. Ojima I., Sun C. M., Zucco M., Park Y. H., Duclos O., Kuduk S. D. Tetrahedron Lett. 34:1993;4149-4152.
25. Ojima I., Habus I., Zhao M., Georg G. I., Jayasinghe R. J. Org. Chem. 56:1991;1681-1684.
26. Ojima I., Habus I., Zhao M., Zucco M., Park Y. H., Sun C. M., Brigaud T. Tetrahedron. 48:1992;6985-7012.
27. Kiikae T., Kirikae F., Oghiso Y., Nakano M. Infect. Immun. 64:1996;3379-3384.
28. Kirikae T., Schade F. U., Kirikae F., Rietchel E. T., Morrison D. C. J. Immunol. 151:1993;2742-2752.
29. Ding A., Sanchez E., Nathan C. F. J. Immunol. 151:1993;5596-5602.
30. Manthey C. L., Vogel S. N. J. Endotoxin Res. 1:1996;189-198.
31. Ding A., Sanchez E., Tancinco M., Nathan C. J. Immunol. 148:1992;2853-2858.
32. Risco C., Domínguez J. E., Bosch M. A., Carrascosa J. L. Mol. Cell. Biochem. 121:1993;67-74.
33. Ding A. H., Porteu F., Sanchez E., Nathan C. F. J. Exp. Med. 171:1990;715-727.
34. Ravindra R., Aronstam R. S. FASEB J. 5:1991;A1498.
35. Ding A., Chen B., Fuortes M., Blum E. J. Exp. Med. 183:1996;1899-1904.
36. Marie S., Ashmid-Alliana A., Kubar J., Ferrua B., Rossi B. J. Biol. Chem. 268:1993;13675-13681.
37. Rietschel E. T., Kirikae T., Shade F. U., Ulmer A. J., Holst O., Brade H., Schmidt G., Mamat U., Grimmecke H.-D., Kusumoto S., Zahringer U. Immunobiol. 187:1993;169-190.
38. Kirikae T., Schade F. U., Zahringer U., Kirikae F., Brade H., Kusumoto S., Kusama T., Rietschel E. T. FEMS Immunol. Med. Microbiol. 8:1994;13-26.
39. Ulmer A. J., Feist W., Heine H., Kirikae T., Kirikae F., Kusumoto S., Kusama T., Brade H., Schade U., Rietschel E. T., Flad H.-D. Infect. Immun. 60:1992;5145-5152.